Advertisement

Index by Author

April 1995; 44 (4)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Andersen, H U

    • Two-dimensional gel electrophoresis of rat islet proteins. Interleukin 1 beta-induced changes in protein expression are reduced by L-arginine depletion and nicotinamide. Diabetes April 1995 44:400-407; doi:10.2337/diabetes.44.4.400

B

  1. Baldoncini, R

    • Plasma endothelin-1 levels in obese hypertensive and normotensive men. Diabetes April 1995 44:431-436; doi:10.2337/diabetes.44.4.431

  2. Banerji, M A

    • Prolongation of near-normoglycemic remission in black NIDDM subjects with chronic low-dose sulfonylurea treatment. Diabetes April 1995 44:466-470; doi:10.2337/diabetes.44.4.466

  3. Bellini, C

    • Plasma endothelin-1 levels in obese hypertensive and normotensive men. Diabetes April 1995 44:431-436; doi:10.2337/diabetes.44.4.431

  4. Bennett, P H

    • Familial relationships between obesity and NIDDM. Diabetes April 1995 44:418-422; doi:10.2337/diabetes.44.4.418

  5. Bhatnagar, D

    • Effect of treatment with a hydroxymethylglutaryl coenzyme A reductase inhibitor on fasting and postprandial plasma lipoproteins and cholesteryl ester transfer activity in patients with NIDDM. Diabetes April 1995 44:460-465; doi:10.2337/diabetes.44.4.460

  6. Bogardus, C

    • Evidence for linkage between a region on chromosome 1p and the acute insulin response in Pima Indians. Diabetes April 1995 44:478-481; doi:10.2337/diabetes.44.4.478

  7. Boulton, A J

    • Effect of treatment with a hydroxymethylglutaryl coenzyme A reductase inhibitor on fasting and postprandial plasma lipoproteins and cholesteryl ester transfer activity in patients with NIDDM. Diabetes April 1995 44:460-465; doi:10.2337/diabetes.44.4.460

  8. Bourey, R

    • Athletes with IDDM exhibit impaired metabolic control and increased lipid utilization with no increase in insulin sensitivity. Diabetes April 1995 44:471-477; doi:10.2337/diabetes.44.4.471

C

  1. Chaiken, R L

    • Prolongation of near-normoglycemic remission in black NIDDM subjects with chronic low-dose sulfonylurea treatment. Diabetes April 1995 44:466-470; doi:10.2337/diabetes.44.4.466

  2. Clark, P M

    • Measurement of proinsulin and intermediates. Validation of immunoassay methods by high-performance liquid chromatography. Diabetes April 1995 44:437-440; doi:10.2337/diabetes.44.4.437

  3. Cohen, N

    • Counterregulation of hypoglycemia. Skeletal muscle glycogen metabolism during three hours of physiological hyperinsulinemia in humans. Diabetes April 1995 44:423-430; doi:10.2337/diabetes.44.4.423

  4. Cole, J A

    • Hyperglycemia-induced changes in Na+/myo-inositol transport, Na(+)-K(+)-ATPase, and protein kinase C activity in proximal tubule cells. Diabetes April 1995 44:446-452; doi:10.2337/diabetes.44.4.446

  5. Coppelli, A

    • Massive isolation, morphological and functional characterization, and xenotransplantation of bovine pancreatic islets. Diabetes April 1995 44:375-381; doi:10.2337/diabetes.44.4.375

  6. Cosimi, S

    • Massive isolation, morphological and functional characterization, and xenotransplantation of bovine pancreatic islets. Diabetes April 1995 44:375-381; doi:10.2337/diabetes.44.4.375

  7. Cox, L J

    • Measurement of proinsulin and intermediates. Validation of immunoassay methods by high-performance liquid chromatography. Diabetes April 1995 44:437-440; doi:10.2337/diabetes.44.4.437

D

  1. Dahlquist, G G

    • Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM. A population-based case-control study. Diabetes April 1995 44:408-413; doi:10.2337/diabetes.44.4.408

  2. Davies, J E

    • Glucose-induced changes in turnover of Na+/H+ exchanger of immortalized lymphoblasts from type I diabetic patients with nephropathy. Diabetes April 1995 44:382-388; doi:10.2337/diabetes.44.4.382

  3. Dean, J

    • Effect of treatment with a hydroxymethylglutaryl coenzyme A reductase inhibitor on fasting and postprandial plasma lipoproteins and cholesteryl ester transfer activity in patients with NIDDM. Diabetes April 1995 44:460-465; doi:10.2337/diabetes.44.4.460

  4. de Courten, M

    • Familial relationships between obesity and NIDDM. Diabetes April 1995 44:418-422; doi:10.2337/diabetes.44.4.418

  5. De Mattia, G

    • Plasma endothelin-1 levels in obese hypertensive and normotensive men. Diabetes April 1995 44:431-436; doi:10.2337/diabetes.44.4.431

  6. Desideri, G

    • Plasma endothelin-1 levels in obese hypertensive and normotensive men. Diabetes April 1995 44:431-436; doi:10.2337/diabetes.44.4.431

  7. Di Francesco, L

    • Plasma endothelin-1 levels in obese hypertensive and normotensive men. Diabetes April 1995 44:431-436; doi:10.2337/diabetes.44.4.431

  8. Durrington, P N

    • Effect of treatment with a hydroxymethylglutaryl coenzyme A reductase inhibitor on fasting and postprandial plasma lipoproteins and cholesteryl ester transfer activity in patients with NIDDM. Diabetes April 1995 44:460-465; doi:10.2337/diabetes.44.4.460

E

  1. Ebeling, P

    • Athletes with IDDM exhibit impaired metabolic control and increased lipid utilization with no increase in insulin sensitivity. Diabetes April 1995 44:471-477; doi:10.2337/diabetes.44.4.471

F

  1. Fernandes, R

    • Familial relationships between obesity and NIDDM. Diabetes April 1995 44:418-422; doi:10.2337/diabetes.44.4.418

  2. Ferri, C

    • Plasma endothelin-1 levels in obese hypertensive and normotensive men. Diabetes April 1995 44:431-436; doi:10.2337/diabetes.44.4.431

  3. Fey, S J

    • Two-dimensional gel electrophoresis of rat islet proteins. Interleukin 1 beta-induced changes in protein expression are reduced by L-arginine depletion and nicotinamide. Diabetes April 1995 44:400-407; doi:10.2337/diabetes.44.4.400

  4. Forsgren, M

    • Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM. A population-based case-control study. Diabetes April 1995 44:408-413; doi:10.2337/diabetes.44.4.408

  5. Furuta, H

    • Association of the prohormone convertase 2 gene (PCSK2) on chromosome 20 with NIDDM in Japanese subjects. Diabetes April 1995 44:389-393; doi:10.2337/diabetes.44.4.389

  6. Furuta, M

    • Association of the prohormone convertase 2 gene (PCSK2) on chromosome 20 with NIDDM in Japanese subjects. Diabetes April 1995 44:389-393; doi:10.2337/diabetes.44.4.389

G

  1. Giannarelli, R

    • Massive isolation, morphological and functional characterization, and xenotransplantation of bovine pancreatic islets. Diabetes April 1995 44:375-381; doi:10.2337/diabetes.44.4.375

  2. Grill, V E

    • Palmitate-induced beta-cell insensitivity to glucose is coupled to decreased pyruvate dehydrogenase activity and enhanced kinase activity in rat pancreatic islets. Diabetes April 1995 44:394-399; doi:10.2337/diabetes.44.4.394

H

  1. Haber, R S

    • Glucocorticoid-induced insulin resistance: dexamethasone inhibits the activation of glucose transport in rat skeletal muscle by both insulin- and non-insulin-related stimuli. Diabetes April 1995 44:441-445; doi:10.2337/diabetes.44.4.441

  2. Halberstam, M

    • Counterregulation of hypoglycemia. Skeletal muscle glycogen metabolism during three hours of physiological hyperinsulinemia in humans. Diabetes April 1995 44:423-430; doi:10.2337/diabetes.44.4.423

  3. Hales, C N

    • Measurement of proinsulin and intermediates. Validation of immunoassay methods by high-performance liquid chromatography. Diabetes April 1995 44:437-440; doi:10.2337/diabetes.44.4.437

  4. Hanson, R L

    • Familial relationships between obesity and NIDDM. Diabetes April 1995 44:418-422; doi:10.2337/diabetes.44.4.418

  5. Hu, M

    • Counterregulation of hypoglycemia. Skeletal muscle glycogen metabolism during three hours of physiological hyperinsulinemia in humans. Diabetes April 1995 44:423-430; doi:10.2337/diabetes.44.4.423

I

  1. Inoue, Y

    • Correction of hypertriglyceridemia with low high-density lipoprotein cholesterol by the novel compound NO-1886, a lipoprotein lipase-promoting agent, in STZ-induced diabetic rats. Diabetes April 1995 44:414-417; doi:10.2337/diabetes.44.4.414

  2. Ivarsson, S

    • Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM. A population-based case-control study. Diabetes April 1995 44:408-413; doi:10.2337/diabetes.44.4.408

J

  1. Janssen, R C

    • Evidence for linkage between a region on chromosome 1p and the acute insulin response in Pima Indians. Diabetes April 1995 44:478-481; doi:10.2337/diabetes.44.4.478

K

  1. Karlsen, A E

    • Two-dimensional gel electrophoresis of rat islet proteins. Interleukin 1 beta-induced changes in protein expression are reduced by L-arginine depletion and nicotinamide. Diabetes April 1995 44:400-407; doi:10.2337/diabetes.44.4.400

  2. Knowler, W C

    • Familial relationships between obesity and NIDDM. Diabetes April 1995 44:418-422; doi:10.2337/diabetes.44.4.418
    • Evidence for linkage between a region on chromosome 1p and the acute insulin response in Pima Indians. Diabetes April 1995 44:478-481; doi:10.2337/diabetes.44.4.478

  3. Koivisto, V A

    • Athletes with IDDM exhibit impaired metabolic control and increased lipid utilization with no increase in insulin sensitivity. Diabetes April 1995 44:471-477; doi:10.2337/diabetes.44.4.471

  4. Koranyi, L

    • Athletes with IDDM exhibit impaired metabolic control and increased lipid utilization with no increase in insulin sensitivity. Diabetes April 1995 44:471-477; doi:10.2337/diabetes.44.4.471

  5. Krolewski, A S

    • Glucose-induced changes in turnover of Na+/H+ exchanger of immortalized lymphoblasts from type I diabetic patients with nephropathy. Diabetes April 1995 44:382-388; doi:10.2337/diabetes.44.4.382

  6. Krolewski, B

    • Glucose-induced changes in turnover of Na+/H+ exchanger of immortalized lymphoblasts from type I diabetic patients with nephropathy. Diabetes April 1995 44:382-388; doi:10.2337/diabetes.44.4.382

  7. Kumar, S

    • Effect of treatment with a hydroxymethylglutaryl coenzyme A reductase inhibitor on fasting and postprandial plasma lipoproteins and cholesteryl ester transfer activity in patients with NIDDM. Diabetes April 1995 44:460-465; doi:10.2337/diabetes.44.4.460

L

  1. Larsen, P M

    • Two-dimensional gel electrophoresis of rat islet proteins. Interleukin 1 beta-induced changes in protein expression are reduced by L-arginine depletion and nicotinamide. Diabetes April 1995 44:400-407; doi:10.2337/diabetes.44.4.400

  2. Lebovitz, H E

    • Prolongation of near-normoglycemic remission in black NIDDM subjects with chronic low-dose sulfonylurea treatment. Diabetes April 1995 44:466-470; doi:10.2337/diabetes.44.4.466

  3. Lindberg, B

    • Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM. A population-based case-control study. Diabetes April 1995 44:408-413; doi:10.2337/diabetes.44.4.408

M

  1. Mackness, M I

    • Effect of treatment with a hydroxymethylglutaryl coenzyme A reductase inhibitor on fasting and postprandial plasma lipoproteins and cholesteryl ester transfer activity in patients with NIDDM. Diabetes April 1995 44:460-465; doi:10.2337/diabetes.44.4.460

  2. Mandrup-Poulsen, T

    • Two-dimensional gel electrophoresis of rat islet proteins. Interleukin 1 beta-induced changes in protein expression are reduced by L-arginine depletion and nicotinamide. Diabetes April 1995 44:400-407; doi:10.2337/diabetes.44.4.400

  3. Marchetti, P

    • Massive isolation, morphological and functional characterization, and xenotransplantation of bovine pancreatic islets. Diabetes April 1995 44:375-381; doi:10.2337/diabetes.44.4.375

  4. Masiello, P

    • Massive isolation, morphological and functional characterization, and xenotransplantation of bovine pancreatic islets. Diabetes April 1995 44:375-381; doi:10.2337/diabetes.44.4.375

  5. McDermott, A M

    • Gi2 and Gi3 proteins mediate the inhibition of adenylyl cyclase by galanin in the RINm5F cell. Diabetes April 1995 44:453-459; doi:10.2337/diabetes.44.4.453

  6. Murase, T

    • Correction of hypertriglyceridemia with low high-density lipoprotein cholesterol by the novel compound NO-1886, a lipoprotein lipase-promoting agent, in STZ-induced diabetic rats. Diabetes April 1995 44:414-417; doi:10.2337/diabetes.44.4.414

N

  1. Nagi, D

    • Measurement of proinsulin and intermediates. Validation of immunoassay methods by high-performance liquid chromatography. Diabetes April 1995 44:437-440; doi:10.2337/diabetes.44.4.437

  2. Nanjo, K

    • Association of the prohormone convertase 2 gene (PCSK2) on chromosome 20 with NIDDM in Japanese subjects. Diabetes April 1995 44:389-393; doi:10.2337/diabetes.44.4.389

  3. Narayan, K M

    • Familial relationships between obesity and NIDDM. Diabetes April 1995 44:418-422; doi:10.2337/diabetes.44.4.418

  4. Navalesi, R

    • Massive isolation, morphological and functional characterization, and xenotransplantation of bovine pancreatic islets. Diabetes April 1995 44:375-381; doi:10.2337/diabetes.44.4.375

  5. Nerup, J

    • Two-dimensional gel electrophoresis of rat islet proteins. Interleukin 1 beta-induced changes in protein expression are reduced by L-arginine depletion and nicotinamide. Diabetes April 1995 44:400-407; doi:10.2337/diabetes.44.4.400

  6. Ng, L L

    • Glucose-induced changes in turnover of Na+/H+ exchanger of immortalized lymphoblasts from type I diabetic patients with nephropathy. Diabetes April 1995 44:382-388; doi:10.2337/diabetes.44.4.382

O

  1. Ohagi, S

    • Association of the prohormone convertase 2 gene (PCSK2) on chromosome 20 with NIDDM in Japanese subjects. Diabetes April 1995 44:389-393; doi:10.2337/diabetes.44.4.389

  2. Ossowski, V M

    • Evidence for linkage between a region on chromosome 1p and the acute insulin response in Pima Indians. Diabetes April 1995 44:478-481; doi:10.2337/diabetes.44.4.478

  3. Ostrega, D

    • Measurement of proinsulin and intermediates. Validation of immunoassay methods by high-performance liquid chromatography. Diabetes April 1995 44:437-440; doi:10.2337/diabetes.44.4.437

P

  1. Paquin, T

    • Glucocorticoid-induced insulin resistance: dexamethasone inhibits the activation of glucose transport in rat skeletal muscle by both insulin- and non-insulin-related stimuli. Diabetes April 1995 44:441-445; doi:10.2337/diabetes.44.4.441

  2. Pettitt, D J

    • Familial relationships between obesity and NIDDM. Diabetes April 1995 44:418-422; doi:10.2337/diabetes.44.4.418

  3. Polonsky, K

    • Measurement of proinsulin and intermediates. Validation of immunoassay methods by high-performance liquid chromatography. Diabetes April 1995 44:437-440; doi:10.2337/diabetes.44.4.437

  4. Pritsker, A

    • Glucocorticoid-induced insulin resistance: dexamethasone inhibits the activation of glucose transport in rat skeletal muscle by both insulin- and non-insulin-related stimuli. Diabetes April 1995 44:441-445; doi:10.2337/diabetes.44.4.441

  5. Prochazka, M

    • Evidence for linkage between a region on chromosome 1p and the acute insulin response in Pima Indians. Diabetes April 1995 44:478-481; doi:10.2337/diabetes.44.4.478

Q

  1. Quinn, P A

    • Glucose-induced changes in turnover of Na+/H+ exchanger of immortalized lymphoblasts from type I diabetic patients with nephropathy. Diabetes April 1995 44:382-388; doi:10.2337/diabetes.44.4.382

R

  1. Rossetti, L

    • Counterregulation of hypoglycemia. Skeletal muscle glycogen metabolism during three hours of physiological hyperinsulinemia in humans. Diabetes April 1995 44:423-430; doi:10.2337/diabetes.44.4.423

S

  1. Sanke, T

    • Association of the prohormone convertase 2 gene (PCSK2) on chromosome 20 with NIDDM in Japanese subjects. Diabetes April 1995 44:389-393; doi:10.2337/diabetes.44.4.389

  2. Santucci, A

    • Plasma endothelin-1 levels in obese hypertensive and normotensive men. Diabetes April 1995 44:431-436; doi:10.2337/diabetes.44.4.431

  3. Shamoon, H

    • Counterregulation of hypoglycemia. Skeletal muscle glycogen metabolism during three hours of physiological hyperinsulinemia in humans. Diabetes April 1995 44:423-430; doi:10.2337/diabetes.44.4.423

  4. Sharp, G W

    • Gi2 and Gi3 proteins mediate the inhibition of adenylyl cyclase by galanin in the RINm5F cell. Diabetes April 1995 44:453-459; doi:10.2337/diabetes.44.4.453

  5. Shima, A

    • Correction of hypertriglyceridemia with low high-density lipoprotein cholesterol by the novel compound NO-1886, a lipoprotein lipase-promoting agent, in STZ-induced diabetic rats. Diabetes April 1995 44:414-417; doi:10.2337/diabetes.44.4.414

  6. Shlimovich, P

    • Counterregulation of hypoglycemia. Skeletal muscle glycogen metabolism during three hours of physiological hyperinsulinemia in humans. Diabetes April 1995 44:423-430; doi:10.2337/diabetes.44.4.423

  7. Siczkowski, M

    • Glucose-induced changes in turnover of Na+/H+ exchanger of immortalized lymphoblasts from type I diabetic patients with nephropathy. Diabetes April 1995 44:382-388; doi:10.2337/diabetes.44.4.382

  8. Stern, M P

    • Diabetes and cardiovascular disease. The "common soil" hypothesis. Diabetes April 1995 44:369-374; doi:10.2337/diabetes.44.4.369

  9. Sweeney, F P

    • Glucose-induced changes in turnover of Na+/H+ exchanger of immortalized lymphoblasts from type I diabetic patients with nephropathy. Diabetes April 1995 44:382-388; doi:10.2337/diabetes.44.4.382

T

  1. Thompson, D B

    • Evidence for linkage between a region on chromosome 1p and the acute insulin response in Pima Indians. Diabetes April 1995 44:478-481; doi:10.2337/diabetes.44.4.478

  2. Tsutsumi, K

    • Correction of hypertriglyceridemia with low high-density lipoprotein cholesterol by the novel compound NO-1886, a lipoprotein lipase-promoting agent, in STZ-induced diabetic rats. Diabetes April 1995 44:414-417; doi:10.2337/diabetes.44.4.414

  3. Tuominen, J A

    • Athletes with IDDM exhibit impaired metabolic control and increased lipid utilization with no increase in insulin sensitivity. Diabetes April 1995 44:471-477; doi:10.2337/diabetes.44.4.471

V

  1. Viacava, P

    • Massive isolation, morphological and functional characterization, and xenotransplantation of bovine pancreatic islets. Diabetes April 1995 44:375-381; doi:10.2337/diabetes.44.4.375

W

  1. Walker, R E

    • Hyperglycemia-induced changes in Na+/myo-inositol transport, Na(+)-K(+)-ATPase, and protein kinase C activity in proximal tubule cells. Diabetes April 1995 44:446-452; doi:10.2337/diabetes.44.4.446

  2. Weinstein, S P

    • Glucocorticoid-induced insulin resistance: dexamethasone inhibits the activation of glucose transport in rat skeletal muscle by both insulin- and non-insulin-related stimuli. Diabetes April 1995 44:441-445; doi:10.2337/diabetes.44.4.441

Y

  1. Yordy, M R

    • Hyperglycemia-induced changes in Na+/myo-inositol transport, Na(+)-K(+)-ATPase, and protein kinase C activity in proximal tubule cells. Diabetes April 1995 44:446-452; doi:10.2337/diabetes.44.4.446

  2. Yoshida, H

    • Association of the prohormone convertase 2 gene (PCSK2) on chromosome 20 with NIDDM in Japanese subjects. Diabetes April 1995 44:389-393; doi:10.2337/diabetes.44.4.389

  3. Yudkin, J

    • Measurement of proinsulin and intermediates. Validation of immunoassay methods by high-performance liquid chromatography. Diabetes April 1995 44:437-440; doi:10.2337/diabetes.44.4.437

Z

  1. Zhou, Y P

    • Palmitate-induced beta-cell insensitivity to glucose is coupled to decreased pyruvate dehydrogenase activity and enhanced kinase activity in rat pancreatic islets. Diabetes April 1995 44:394-399; doi:10.2337/diabetes.44.4.394

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement